- The new Johnson & Johnson vaccine will add up to 20 million doses by the end of March, expanding the number of doses available over the next month by up to 25%. At least 20% of the nation's adults have received at least one dose of the vaccine.
- Still, the supply of available doses does not match demand. As states open up eligibility to younger and healthier individuals, there could be shortages in some areas for the next couple of months.
- A $1.9 trillion relief bill was pushed through the House this weekend and will now move on to the Senate. The bill will provide direct assistance through checks to millions of Americans, as well as unemployment assistance and numerous other benefits.
- Though vaccination rates continue to climb, some experts fear that states are too quickly easing COVID-19 safety guidelines and restrictions.
- As the U.S. marks the anniversary of the first COVID deaths in the country, some people want to make March 1 a day of COVID remembrance .
- Who are the groups of people in the United States who have been vaccinated at high rates already?
- What are some ways the Johnson and Johnson vaccine differs from the two other vaccines already on the market?
- Where and When will the vaccine be distributed?
- Why are some experts worried that states are opening up too quickly?
- How do states decide who is eligible for vaccination?
- How should states decide who is eligible for a vaccine now that more are available (but not enough yet for everyone)?
- What has the process for vaccine distribution been like in your state? How can you find out, if you're not sure?
- Want to help members of your community get registered for a vaccination? Use this full lesson or this guide to explore how to get vaccinated in your own community.